Your browser doesn't support javascript.
Acquired thrombotic thrombocytopenic purpura with possible association with AstraZeneca-Oxford COVID-19 vaccine.
Al-Ahmad, Mona; Al-Rasheed, Mona; Shalaby, Neveen Abo Bakr.
  • Al-Ahmad M; Microbiology Department Faculty of Medicine Kuwait University Kuwait Kuwait.
  • Al-Rasheed M; Al Rashed Allergy Centre Ministry of Health Kuwait.
  • Shalaby NAB; Hematology Unit Department of Medicine Al Adnan Hospital Ministry of Health Kuwait.
EJHaem ; 2(3): 534-536, 2021 Aug.
Article in English | MEDLINE | ID: covidwho-1233204
ABSTRACT
Acquired thrombotic thrombocytopenic purpura is characterized by the microvascular aggregation of platelets and microangiopathic hemolytic anemia causing ischemia of multiple organs including the brain mainly and less likely the kidney and the heart. The disease is caused by severe reduction in the activity of ADAMTS 13 due to presence of inhibitory antibodies.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report Topics: Vaccines Language: English Journal: EJHaem Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report Topics: Vaccines Language: English Journal: EJHaem Year: 2021 Document Type: Article